Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients

Gastroenterology

Volumn 123, Issue 6, 2002, Pages 1848-1856

  Sánchez Tapias, José M ^a,b   Costa, Josep ^a   Mas, Antoni ^a   Bruguera, Miquel ^a   Rodés, Juan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADULT; ARTICLE; CHRONIC HEPATITIS; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; REMISSION; SEROCONVERSION; SPAIN; VIROLOGY;

EID: 0036892321     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.37041     Document Type: Article

References (44)

1. Hoofnagle JH, Shafritz DA, Popper H. Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology 1987;7:758-763.
2. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-1745.
3. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewinjo RI, Imai M, Miyakawa Y, Mayumi M. Typing of hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes. J Gen Virol 1988;69:2575-2583.
4. Norder H, Couroucé AM, Magnius LO. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994;198:489-503.
5. Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S gene. Intervirology 1995;38:24-34.
6. Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R. A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness. J Gen Virol 2000;81:67-74.
7. Norder H, Hammas B, Lee SD, Bile K, Courouce AM, Mushahwar IK, Magnius LO. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol 1993;74:1341-1348.
8. Rodríguez-Frías F, Buti M, Jardí R, Cotrina M, Viladomíu L, Esteban R, Guardia J. Hepatitis B virus infection: Precore mutants and its relation to viral genotypes and core mutations. Hepatology 1995;22:1641-1647.
9. Lindh M, Andersson A-S, Gusdal A. Genotypes, nt1858 variants, and geographic origin of hepatitis B virus. Large scale analysis using a new genotyping method. J Infect Dis 1996;175:1285-1293.
10. Telenta PF, Poggio GP, López JL, González J, Lemberg A, Campos RH. Increased prevalence of genotype F hepatitis B virus isolates in Buenos Aires, Argentina. J Clin Microbiol 1997;35:1873-1875.
11. Arauz-Ruiz P, Norder H, Visona KA, Magnius LO. Genotype F prevails in HBV infected patients of Hispanic origin in Central America and may carry the precore stop mutant. J Med Virol 1997;51:305-312.
12. Orito E, Mizokami M, Sakugawa H, Michitaka K, Ishikawa K, Ichida T, Okanoue T, Yotsuyanagi H, Iino S for the Japan HBV genotype Research Group. A case-control study for clinical and molecular biological differences between hepatitis viruses of genotypes B and C. Hepatology 2001;33:218-223.
13. Naito H, Hayashi S, Abe K. Rapid and specific genotyping system for hepatitis B virus corresponding to six major genotypes by PCR using type-specific primers. J Clin Microbiol 2001;39:362-364.
14. Ding X, Mizokami M, Yao G, Xu B, Orito E, Ueda R, Nakanishi M. Hepatitis B virus distribution among chronic hepatitis B carriers in Shangai, China. Intervirology 2001;44:43-47.
15. Lindh M, Horal P, Dhillon AP, Furuta Y, Norkrans G. Hepatitis B virus carriers without precore mutations in anti-HBe-negative stage show more severe liver damage. Hepatology 1996;24:494-501.
16. Grandjacques C, Pradat P, Stuyver L, Chevallier M, Chevallier P, Pichoud C, Maisonnas M, Trepo C, Zoulim F. Rapid detection of genotypes and mutations in the pre-core promoter and the precore region of hepatitis B virus genome: Correlation with viral persistence and disease severity. J Hepatol 2000;33:430-439
17. Kao J-H, Chen P-J, Lai M-Y, Chen D-S. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 2000;118:554-559.
18. Fujie H, Moriya K, Shintani Y, Yotsuyanagi H, Iino S, Kimura S, Koike K. Hepatitis B virus and hepatocellular carcinoma in japan (letter). Gastroenterology 2001;120:1564.
19. Chu CJ, Hussain M, Lok ASF. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 2002;122:1756-1762.
20. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading, and staging. Hepatology 1994;19:1513-1520.
21. Scheuer PJ. Classification of chronic hepatitis: A need for reassessment. J Hepatol 1991;1;372-374.
22. Krogsgaard K, Marcellin P, Trepo C, Berthelot P, Sánchez-Tapias JM, Bassendine M, Tran A, Ouzan D, Ring-Larsen H, Lindberg J, Enriquez J, Benhamou JP, Bindslev N. Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. J Hepatol 1996;25:803-813.
23. Scotto J, Hadchouel M, Hery C, Yvart J, Tiollais P, Brechot C. Detection of hepatitis B virus DNA in serum by a single spot hybridization technique: Comparison with results for other viral markers. Hepatology 1983;3:279-284.
24. Costa J, López-Labrador FX, Sánchez-Tapias JM, Mas A, Vilella A, Olmedo E, Vidal JM, Jiménez de Anta MT, Rodés J. Microwave treatment of serum facilitates detection of hepatitis B virus DNA by the polymerase chain reaction. Results of a study in anti-HBe positive chronic hepatitis B. J Hepatol 1995;21:35-42.
25. Yuen MF, Hui CK, Cheng CC, Wu CH, Lai YP, Lai CL. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B virus infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications. Hepatology 2001;34:139-145.
26. Niederau C, Heintges T, Lange S, Goldman G, Niederau CM, Mohr L, Haussinger D. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996;334:1422-1427.
27. Lau DTY, Everhart J, Kleiner DE, Park Y, Vergalla J, Schmid P, Hoofnagle JH. Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa. Gastroenterology 1997;113:1660-1667.
28. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000 - Summary of a workshop. Gastroenterology 2001;120:1828-1853.
29. Perrillo RP, Brunt EM. Hepatic histologic and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e and hepatitis B surface antigen. Ann Intern Med 1991;115:113-115.
30. De Franchis R, Meucci G, Vecchi M, Tatarella M, Colombo M, Del Ninno E, Rumi MG, Donato MF, Ronchi G. The natural history of hepatitis B surface antigen carriers. Ann Intern Med 1993;118:191-194.
31. Villeneuve JP, Desrochers M, Infante-Rivard C, Willems B, Raymond G, Bourcier M, Cote J, Richer G. A long-term follow-up study of asymptomatic hepatitis B surface antigen carriers in Montreal. Gastroenterology 1994;106:1000-1005.
32. Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, Uaw YF. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002;35:1522-1527.
33. Brunetto MR, Oliveri F, Rocca G, Criscuolo D, Chiaberge E, Capalbo M, David E, Verme G, Bonino F. Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen. Hepatology 1989;10:198-202.
34. Fattovich G, Brollo L, Alberti A, Pontisso P, Giustina G, Realdi G. Long-term follow-up of anti-HBe positive chronic hepatitis B. Hepatology 1988;8:1651-1654.
35. Hadziyannis SJ, Vassilpoulos D. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 2001;34:617-624.
36. Sampliner RE, Hamilton FA, Iseri OA, Tabor E, Boitnott J. The liver histology and frequency of clearance of the hepatitis B surface antigen (HBsAg) in chronic carriers. Am J Med Sci 1979;277:17-22.
37. Viola LA, Barrison IG, Coleman JC, Paradinas FJ, Fluker JL, Evans BA, Murray-Lyon IM. Natural history of liver disease in chronic hepatitis B surface antigen carriers. Lancet 1981;2:1156-1159.
38. Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: A prospective study. Hepatology 1991;13:627-631.
39. Di Marco V, Lo Iacono O, Cammà C, Vaccaro A, Giunta M, Martorana G, Fuschi P, Almasio PL, Craxì A. The long-term course of chronic hepatitis B. Hepatology 1999;30:257-264.
40. Fattovich G, Giustina G, Sánchez-Tapias J, Quero C, Mas A, Olivotto PG, Solinas A, Almasio P, Hadzyannis S, Degos F, Carneiro de Moura M, Krogsgaard K, Pantalena M, Realdi G, Corrocher R, Schalm SW, and the European concerted action on viral hepatitis (EUROHEP). Delayed clearance of serum HBsAg in compensated cirrhosis B. Relation to interferon alpha therapy and disease prognosis. Am J Gastroenterol 1998;93:896-900.
41. Li JS, Tong SP, Wen YM, Vitvitski L, Zhang Q, Trepo C. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: Possible contribution of a single nucleotide in the precore region. J Virol 1993;67:5402-5410.
42. Lindh M, Furuta Y, Vahine A, Norkrans G, Horal P. Emergence of precore TAG mutation during hepatitis B e seroconversion and its dependence on pregenomic base pairing between nucleotides 1858 and 1896. J Infect Dis 1995;172:1343-1347.
43. Lok ASF, Akarca U, Green S. Mutations in the pre-core region of hepatitis B virus region serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc Natl Acad Sci U S A 1994;91:4077-4081.
44. Loriot MA, Marcellin P, Talbodec N, Guigonis V, Gigou M, Boyer N, Bezeaud A, Erlinger S, Benhamou JP. Low frequency of precore hepatitis B virus mutants in anti-HBe-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B. Hepatology 1995;22:627-631.